Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement.
Rosta L, Menyhart A, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kapoor N, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Kempler P, Rizzo M. Rosta L, et al. Among authors: cosentino f. Front Endocrinol (Lausanne). 2023 May 17;14:1129793. doi: 10.3389/fendo.2023.1129793. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37265696 Free PMC article. Review.
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence.
Mainas G, Nibali L, Ide M, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janež A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO). Mainas G, et al. Among authors: cosentino f. Metabolites. 2022 Dec 26;13(1):40. doi: 10.3390/metabo13010040. Metabolites. 2022. PMID: 36676965 Free PMC article. Review.
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel.
Popovic DS, Papanas N, Koufakis T, Kotsa K, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kempler P, Kapoor N, Lessan N, Lotufo P, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M. Popovic DS, et al. Among authors: cosentino f. Exp Clin Endocrinol Diabetes. 2023 May;131(5):260-267. doi: 10.1055/a-2019-1111. Epub 2023 Jan 24. Exp Clin Endocrinol Diabetes. 2023. PMID: 36693416 Review.
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.
Pantea Stoian A, Bica IC, Salmen T, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Mikhailidis DP, Nibali L, Papanas N, Powell-Wiley T, Rizvi AA, Sahebkar A, Santos RD, Toth PP, Viswanathan V, Rizzo M; Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO). Pantea Stoian A, et al. Among authors: cosentino f. Diabetes Ther. 2024 Jan;15(1):33-60. doi: 10.1007/s13300-023-01465-7. Epub 2023 Sep 26. Diabetes Ther. 2024. PMID: 37751143 Free PMC article. Review.
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.
Pantea Stoian A, Bica IC, Salmen T, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Mikhailidis DP, Nibali L, Papanas N, Powell-Wiley T, Rizvi AA, Sahebkar A, Santos RD, Toth PP, Viswanathan V, Rizzo M; Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO). Pantea Stoian A, et al. Among authors: cosentino f. Diabetes Ther. 2024 Jan;15(1):297-299. doi: 10.1007/s13300-023-01494-2. Diabetes Ther. 2024. PMID: 37964156 Free PMC article. No abstract available.
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.
Ceriello A, Rodbard HW, Battelino T, Brosius F, Cosentino F, Green J, Ji L, Kellerer M, Koob S, Kosiborod M, Lalic N, Marx N, Nedungadi TP, Parkin CG, Rydén L, Sheu WH, Standl E, Vandvik PO, Schnell O; Taskforce of the Guideline Workshop. Ceriello A, et al. Among authors: cosentino f. Cardiovasc Diabetol. 2023 Oct 13;22(1):277. doi: 10.1186/s12933-023-01993-3. Cardiovasc Diabetol. 2023. PMID: 37833776 Free PMC article.
Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop.
Gavin JR, Rodbard HW, Battelino T, Brosius F, Ceriello A, Cosentino F, Giorgino F, Green J, Ji L, Kellerer M, Koob S, Kosiborod M, Lalic N, Marx N, Prashant Nedungadi T, Parkin CG, Topsever P, Rydén L, Huey-Herng Sheu W, Standl E, Olav Vandvik P, Schnell O. Gavin JR, et al. Among authors: cosentino f. Diabetes Res Clin Pract. 2024 May;211:111666. doi: 10.1016/j.diabres.2024.111666. Epub 2024 Apr 12. Diabetes Res Clin Pract. 2024. PMID: 38616041 Review.
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin.
Corbin KD, Dagogo-Jack S, Cannon CP, Cherney DZI, Cosentino F, Frederich R, Liu J, Pong A, Lin J, Cater NB, Pratley RE. Corbin KD, et al. Among authors: cosentino f. Diabetes Obes Metab. 2023 Mar;25(3):758-766. doi: 10.1111/dom.14923. Epub 2022 Dec 26. Diabetes Obes Metab. 2023. PMID: 36394384 Clinical Trial.
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
Kim JM, Bhatt DL, Dagogo-Jack S, Cherney DZI, Cosentino F, McGuire DK, Pratley RE, Liu CC, Cater NB, Frederich R, Mancuso JP, Cannon CP. Kim JM, et al. Among authors: cosentino f. Diabetes Obes Metab. 2023 May;25(5):1398-1402. doi: 10.1111/dom.14965. Epub 2023 Feb 14. Diabetes Obes Metab. 2023. PMID: 36594154 No abstract available.
Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial.
Pratley RE, Cannon CP, Cherney DZI, Cosentino F, McGuire DK, Essex MN, Lawrence D, Jones PLS, Liu J, Adamsons I, Dagogo-Jack S. Pratley RE, et al. Among authors: cosentino f. Lancet Healthy Longev. 2023 Apr;4(4):e143-e154. doi: 10.1016/S2666-7568(23)00032-6. Lancet Healthy Longev. 2023. PMID: 37003273 Free article. Clinical Trial.
528 results